Who We Are

With teams led by biopharma development professionals, Uniphar (formerly RRD) can accelerate drug development thanks to a unique partnership model. We strategize, optimize, and execute to ensure efficiency and achieve value.

What We Do and Our Solutions

01 Accelerate Drug Development and Reduce Risk

02 Patient Benefit and Impact

03 Rapid Start with High Caliber Team

04 Improve Asset Value

01 Accelerate Drug Development and Reduce Risk

We use experience and strategy to deploy the right resource at the right time to accelerate your asset’s development.

How do we do this?

Our strategic focus, development expertise and CRO/vendor oversight supports optimal asset development.

Value Creation

02 Patient Benefit and Impact

Our ownership mindset means we are invested in the success of your asset and the value it can bring to patients’ lives.

How do we do this?

Our experienced team support asset biopharma development at any stage and reduce risk to optimize time to treatment.

Value Creation

03 Rapid Start with High Caliber Team

Our broad development perspective across the organization avoids silo working for promoting maximum efficiency.

How do we do this?

Experienced plug and play development team, ready to go when you need them.

Value Creation

04 Improve Asset Value

We focus constrained resources and capital on building asset value rather than investing in high-risk activities that have lower, longer ROI.

How do we do this?

Asset-centric model driven to succeed by strategizing, optimizing, and executing.

Value Creation

01 Accelerate Drug Development and Reduce Risk

We use experience and strategy to deploy the right resource at the right time to accelerate your asset’s development.

How do we do this?

Our strategic focus, development expertise and CRO/vendor oversight supports optimal asset development.
Our Values ›

02 Patient Benefit and Impact

Our ownership mindset means we are invested in the success of your asset and the value it can bring to patients’ lives.

How do we do this?

Our experienced team support asset biopharma development at any stage and reduce risk to optimize time to treatment.
Value Creation ›

03 Rapid Start with High Caliber Team

Our broad development perspective across the organization avoids silo working for promoting maximum efficiency.

How do we do this?

Experienced plug and play development team, ready to go when you need them.
Value Creation ›

04 Improve Asset Value

We focus constrained resources and capital on building asset value rather than investing in high-risk activities that have lower, longer ROI.

How do we do this?

Asset-centric model driven to succeed by strategizing, optimizing, and executing.
Value Creation ›

We use experience and strategy to deploy the right resource at the right time to accelerate your asset’s development.

How do we do this?

Our strategic focus, development expertise and CRO/vendor oversight supports optimal asset product development.

Our Values

function myFunction() { var x = document.getElementById("myDIV"); if (x.style.display === "block") { x.style.display = "none"; } else { x.style.display = "block"; } }

Our ownership mindset means we are invested in the success of your asset and the value it can bring to patients’ lives.

How do we do this?

Our experienced team support asset biopharma development at any stage and reduce risk to optimize time to treatment.

Value Creation

Uniphar’s (formerly RRD) partnering model is designed to accelerate drug development and increase asset value delivered in a framework of quality and compliance to achieve a higher probability of successful outcomes.

Explore our Pharma Division